BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 18751917)

  • 41. Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases.
    Van Eden W; Wick G; Albani S; Cohen I
    Ann N Y Acad Sci; 2007 Oct; 1113():217-37. PubMed ID: 17584980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How much is too much? Interleukin-6 and its signalling in atherosclerosis.
    Schuett H; Luchtefeld M; Grothusen C; Grote K; Schieffer B
    Thromb Haemost; 2009 Aug; 102(2):215-22. PubMed ID: 19652871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A; Beissert S; Krammer PH
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression.
    Tsimikas S; Aikawa M; Miller FJ; Miller ER; Torzewski M; Lentz SR; Bergmark C; Heistad DD; Libby P; Witztum JL
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):175-81. PubMed ID: 17082490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role and function of macrophages in the metabolic syndrome.
    Bhargava P; Lee CH
    Biochem J; 2012 Mar; 442(2):253-62. PubMed ID: 22329799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis.
    Zerrad-Saadi A; Therond P; Chantepie S; Couturier M; Rye KA; Chapman MJ; Kontush A
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2169-75. PubMed ID: 19762782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis.
    Cusi K
    Clin Liver Dis; 2009 Nov; 13(4):545-63. PubMed ID: 19818304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions.
    Catalá A
    Chem Phys Lipids; 2009 Jan; 157(1):1-11. PubMed ID: 18977338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-1 beta targeted therapy for type 2 diabetes.
    Maedler K; Dharmadhikari G; Schumann DM; Størling J
    Expert Opin Biol Ther; 2009 Sep; 9(9):1177-88. PubMed ID: 19604125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral inflammatory process and general health. Part 1: The focal infection and the oral inflammatory lesion.
    Somma F; Castagnola R; Bollino D; Marigo L
    Eur Rev Med Pharmacol Sci; 2010 Dec; 14(12):1085-95. PubMed ID: 21375141
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammation and immunity in diabetic vascular complications.
    Nilsson J; Bengtsson E; Fredrikson GN; Björkbacka H
    Curr Opin Lipidol; 2008 Oct; 19(5):519-24. PubMed ID: 18769234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of inflammation in atherosclerosis associated with rheumatoid arthritis.
    Libby P
    Am J Med; 2008 Oct; 121(10 Suppl 1):S21-31. PubMed ID: 18926166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Vitamin D insufficiency--possible etiologic factor of autoimmune diseases].
    Jørgensen SP; Bartels LE; Agnholt J; Glerup H; Nielsen SL; Hvas CL; Dahlerup JF
    Ugeskr Laeger; 2007 Oct; 169(43):3655-60. PubMed ID: 17967265
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of innate immune responses in autoimmune disease development.
    Waldner H
    Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-inflammatory properties of lipid oxidation products.
    Bochkov VN; Leitinger N
    J Mol Med (Berl); 2003 Oct; 81(10):613-26. PubMed ID: 13679995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel immune assay for quantification of plasma protective capacity against oxidized phospholipids.
    Bochkov V; Schoenenberger AW; Oskolkova O; Toth U; Stöckl J; Majdic O; Daci A; Resink TJ; Erne P; Philippova M
    Biomark Med; 2016 Aug; 10(8):797-810. PubMed ID: 27416002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipid peroxidation: physiological levels and dual biological effects.
    Niki E
    Free Radic Biol Med; 2009 Sep; 47(5):469-84. PubMed ID: 19500666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective.
    Wilson PW
    Am J Med; 2008 Oct; 121(10 Suppl 1):S15-20. PubMed ID: 18926165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rheumatoid arthritis and lupus erythematosus from a defect in inflammation--a hypothesis.
    Stone OJ
    Tex Rep Biol Med; 1969; 27(2):323-6. PubMed ID: 5350359
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.